Antibody response to insulin aspart and human insulin in children and adolescents with newly diagnosed type 1 diabetes

被引：0
|
作者：
Holmberg, Hanna
Mersebach, Henriette
Hanzel, Karin Kanc
Ludvigsson, Johnny
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A476 / A476
页数：1
相关论文
共 50 条
  • [21] Insulin Edema in Newly Diagnosed Type 1 Diabetes Patient
    Oguz, Ayten
    Tuzun, Dilek
    Sahin, Murat
    Atay, Didem
    Ganidagli, Berivan
    Gul, Kamile
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2016, 20 (03) : 97 - 99
  • [22] Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial
    Bode, Bruce W.
    Iotova, Violeta
    Kovarenko, Margarita
    Laffel, Lori M.
    Rao, Paturi V.
    Deenadayalan, Srikanth
    Ekelund, Magnus
    Larsen, Steffen Falgreen
    Danne, Thomas
    DIABETES CARE, 2019, 42 (07) : 1255 - 1262
  • [23] The comparison of insulin aspart and human soluble insulin used in continuous subcutaneous insulin infusion in newly diagnosed type 2 diabetic patients
    Li, Y
    Liu, J
    Liao, Z
    Huang, ZM
    Weng, HP
    DIABETES, 2005, 54 : A106 - A107
  • [24] Long-term efficacy and safety of insulin degludec in combination with bolus insulin aspart in children and adolescents with type 1 diabetes
    Thalange, N.
    Deeb, L. C.
    Iotova, V.
    Kawamura, T.
    Klingensmith, G. J.
    Philotheou, A.
    Silverstein, J.
    Tumini, S.
    Francisco, A. Ocampo
    Kinduryte, O.
    Danne, T.
    DIABETOLOGIA, 2014, 57 : S395 - S395
  • [25] Influence of initial insulin dosage on blood glucose dynamics of children and adolescents with newly diagnosed type 1 diabetes mellitus
    Wang, Yi
    Gong, Chunxiu
    Cao, Bingyan
    Meng, Xi
    Wei, Liya
    Wu, Di
    Liang, Xuejun
    Li, Wenjing
    Liu, Min
    Gu, Yi
    Su, Chang
    PEDIATRIC DIABETES, 2017, 18 (03) : 196 - 203
  • [26] Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes
    Lindholm, A
    Jensen, LB
    Home, PD
    Raskin, P
    Boehm, BO
    Råstam, J
    DIABETES CARE, 2002, 25 (05) : 876 - 882
  • [27] How effective is biphasic insulin aspart in the treatment of adolescents with type 1 diabetes?
    Joseph I Wolfsdorf
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 486 - 487
  • [28] How effective is biphasic insulin aspart in the treatment of adolescents with type 1 diabetes?
    Wolfsdorf, Joseph I.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (09): : 486 - 487
  • [29] Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus
    Fath, Maryam
    Danne, Thomas
    Biester, Torben
    Erichsen, Lars
    Kordonouri, Olga
    Haahr, Hanne
    PEDIATRIC DIABETES, 2017, 18 (08) : 903 - 910
  • [30] The association between anti-insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in children and adolescents with type 1 diabetes
    Biester, Torben
    von Dem Berge, Thekla
    Bendtsen, Line Quist
    Bendtsen, Mette Dahl
    Rathor, Naveen
    Danne, Thomas
    Haahr, Hanne
    PEDIATRIC DIABETES, 2020, 21 (05) : 781 - 790
12345